Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The concurrent is no different from the history. NeverCides jumps from one flavor of the month to another because they can't address any of them. They have never made made two useful batches of the same of any of their drugs and that, my friend, is a game ended.
Despite this fact being the number one issue -- and arguably the only issue that's important -- Seymour barely mentioned it if he mentioned it at all at the AGM. He's perfectly willing to collected retroactive bloated salaries and bonuses financed by naive investors who aren't even aware of the main issue that renders much of Seymour's claims to be total bullshit.
Seymour said the delay in TOX was just waiting on BASI to be ready for more material and was out of his hands.
lol
Not a lie?
Remember Seymour lying that NeverCides is only waiting on BASI to be ready for more material to continue TOX?
lol
Most of us knew that was a steaming pile of bullshit and now all of us know that.
What's worse is the test on 6,000 animals was on a drug that doesn't exist since they haven't been able to duplicate it.
It's the FDA equivalent of blindly grabbing random ingredients off a shelf and having no record or memory of what those ingredients were.
Of course NeverCides never publishes their results so that others can verify and recreate their experiments -- even NeverCides can't recreate them.
It doesn't matter what standard NeverCides tests -- they don't have anything to test.
NeverCides even warns it needs consistently and to be able to duplicated multiple useful batches of drug in order to even think about testing. 12 years later they can't even do this task.
Game over.
NeverCides can't manufacture any useful batches of drugs under CGMP, GLP, GLP-like, GMP-like, GLP-love, in America, in Australia, in Brazil, or even on the moon.
None of that shit really matters.
What matters is every batch of size NeverCides makes is as unique as a snowflake is and is completely worthless. We can talk about the conditions of which NeverCides actually made two batches that look alike when NeverCides actually makes two batches that look alike. Until then, we might as well be talking about the mating patterns of unicorns.
You "forgot" the very next line:
"When drug development reaches the stage where the drug products are produced for clinical trials in humans or animals, then compliance with the CGMP regulations is required."
We all know exactly how 2017 is going to play out.
Whether we decide to accept what we all already know is up to the individual. Reality with this trash sucks so it's up to the individual to embrace reality or not.
NNVC has better than patents -- NeverCides has the ability to replicate a single useful batch kept so safe from competitors that even nobody at NeverCides can do it.
No trades on a holiday when the entire market was closed. Weird.
lol
Apparently those trade secrets are so secret even nobody at NNVC knows how to make any worthwhile drug batches.
You're welcome.
The problem is when Seymour says he can have "a" drug for you in a few weeks he means that literally since he can't make a duplicate batch of "a" drug. By the way, without duplication and consistent batches NNVC is dead on arrival. They got zilch.
It's not my fault NNVC has been caught lying again and committing fraud.
There are no business prospects for NNVC -- that's the same point and the motive for the fraud lies.
NNVC wants naive investors to believe they are currently developing an Ebola drug and this is a full fledged biotech company with lots of irons in the fire. It's a lie. They are a one trick pony that can't even replicate the same trick twice.
NNVC is dying. Some of us prefer to encourage investors to attend the funeral and watch from the sides rather than end up financially next to this scam in the coffin.
Back-burner? No. Try suspended. For example, when NNVC's stock gets suspended anybody can call it "back burner" trading if they want to try to be cute but the SEC has a different name for it.
I prefer reality instead of bullshit. In August they lied and said they are currently developing drugs for Ebola and Zika and every press release toward the bottom still says they are now working on Ebola.
Why is NNVC claiming to be CURRENTLY developing drugs when the programs for those drugs have been suspended when doing so constitutes fraud?
Anybody discovering NNVC for the first time via their fraud press release may be fooled into think NNVC is currently developing Ebola and Zika drugs when in reality that is false and fraud.
Thanks for quoting the completion date section out of context, but NNVC makes it crystal clear that they are NOT currently developing any Ebola drug:
"We have suspended this program"
"This program can be restarted if non-dilutive funding becomes available."
Then again since NNVC has trouble keeping their lies straight, I wouldn't be surprised if more conflicting info beyond the PRs is found. That's how scams like NNVC get caught.
It's a suspended background project for which they are NOT currently developing. It's a fraud and a lie for NNVC to claim to be CURRENTLY developing Ebola when they are NOT developing Ebola. This is exactly the type of fraud the SEC warns about.
"This program can be restarted if non-dilutive funding becomes available."
AKA not restarted currently. AKA any claims of currently developing an Ebola drug is a fraud.
What part of "We have suspended this program" is vague and leads anybody to conclude NNVC is currently working on a program that has already been suspended?
"Project 7 EbolaCide™: Anti-Ebola nanoviricide
Current status
We have suspended this program."
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11596687 September 16, 2016
Good grief x2. No program = not "working on Zika" no matter how much work the did in the past before SUSPENDING the program it is a fraud lie to tout "currently working" just like the SEC warns.
As for Ebola -- keep reading. The filings make it even more clear by specifically spelling out the Ebola program has been suspended yet NNVC continues to tout it as current just like the SEC warns.
It's real simple -- the SEC warns about fake Ebola and Zika associations are being fraudulently touted by scam companies.
NNVC is fraudulently touting Ebola and Zika programs in its press releases.
NNVC's own SEC filings deny these programs even exist.
Where that bullshit breaks down is NNVC's own SEC filings warn the Ebola program has been suspended and the Zika program doesn't even exist.
Wow Seymour has balls! His own SEC filings state they have no Zika program at all and won't have one unless funded first.
NNVC's own SEC filings say the Ebola program has been SUSPENDED yet they continue to tout otherwise?
LOL how is this not severe fraud by NNVC?
Why bother bullshitting the un-bullshit-able?
FINRA Investor Alert Warns About Scams Touting Ebola Cure and Other Viral Disease Stock Schemes
by Shepherd Smith Edwards & Kantas LTD LLP
The Financial Industry Regulatory Authority has put out an investor alert warning against buying stocks in companies claiming to combat viral diseases. The self-regulatory organization says it knows of several possible schemes involving stock promotions employing tactics such as pump-and-dump scams to inflate share prices. The scammers will then sell their shares at a profit while leaving investors with shares that have lost their value.
Intensified news coverage of the recent Ebola and Middle East Respiratory Syndrome outbreak will likely have attracted the attention of stock scammers wanting to take advantage of people’s fears. To avoid falling victim to a viral disease stock scam, FINRA is offering several tips, including:
• Be wary of promotional materials, correspondence, and press releases from senders you don’t know. Watch out for communications that say little about the risks involved while only touting the positives. Getting a barrage of information about the same stock opportunities can also be a red flag.
• Make sure to know who is behind a company you are thinking of investing in. Do your research. Think twice if company officials have past criminal records or you hear anything negative in the news. Be on the look out for fake business addresses and phone numbers.
• A lot of stock pump-and-dump scams don’t trade on the NYSE or other registered national securities exchanges. Instead, you can find them on OTC quotations platforms or alternative trading systems.
• Find out whether the company submitted an SEC filing. Compare the information there with what’s provided in promotional materials and other communications you’ve received. Watch out for solicitations to get you to invest in products that are still being developed or if there are losses on balance sheets.
• Watch out if a company keeps changing its name or business focus.
• Make sure you read the fine print and be wary when name-dropping is used to gain investor confidence or boost legitimacy.
Only the companies suspending are claiming they didn't do Ebola work -- the SEC disagrees:
https://www.sec.gov/litigation/suspensions/2014/34-73650-o.pdf
Blindly relying on company claims has destroyed the lives of many NNVC investors. It would be a good sign of learning if we put a little more weight in the SEC's claims vs. a suspended stock scam's claims.
Have you heard of dengue?
Isn't Seymour good looking? True that pic was from years ago so no doubt he's gotten more studly as he ages into his 80s
I agree -- Seymour walks around with a "kick me" sign on his ass. How can one possibly resist?
lol you beat with on the golf example. A game of golf becomes boring history nobody cares about over time.
True Crime snake oil scams become fascinating history forever!
Bonus -- we get to do it from our smartphones WHILE play golf (or in my case drinking in the clubhouse)
Personally I can't imagine why people spend their lives hitting tiny white balls into holes in giant fields while wearing one glove, a dorky hat, and roast in the sun the entire time.
Luckily I'm intelligent enough to understand people who play golf enjoy it and I don't need to come up with some ridiculous conspiracy theory as to why they play.
Some people like playing golf, which I find terribly bizarre -- I like exposing stock scams like NNVC. I can't imagine why there are entire TV channels devoted to golf but I certainly understand why there are True Crime networks such as TruTV. Some of us love these shows and then take the additional step of following these true crimes stories live while they are happening and even pariticipate in interacting with some of the criminals through social media.
I can't fathom how anyone does NOT see the addictive entertainment value.
Let's just hope that block is more meaningful than the 1 million share block at $4 purchased by "Dave"
The short cabal must be scared over a warrant dividend that creates zero covering pressure. Look at NeverCides soar!
Or is it sore?
Very sore!
The best idea for a short squeeze....
Do a 100 for 1 split even if only temporary (can reverse it back later).
That would put the stock price at $0.01 where most brokerage houses won't allow shares to be held short without a massive amount of equity either 25 or 50 to 1. That puts at max a 4% or 2% return on all that locked up capital. No good to most shorts.
Covering wound begin fast -- as in day 1 and be complete at worst within a week.
No white paper needed. You're welcome.
I so hope the warrant dividend idea goes through with a 5 year non-transferable feature so that every investor who is watching his shares continue to implode into the abyss has to stare at the warrant stuck in his account like a Scarlet Letter.
One can reproduce/replicate something only when it is known precisely what is to be reproduced. At this stage the knowledge on most of the nanoparticulate drug formulations is far from adequate and the old question ‘What's in the bottle?’’ continues to frustrate researchers. It is even more worrying that, despite all these hurdles having been known for a long time, the primary research focus continues to be on developing new formulations instead of tackling the synthetic, analytical and experimental challenges that already exist and inhibit translation. There is already a sufficiently high number of NPs present for drug delivery purposes and we therefore need to prioritize overcoming these challenges instead of producing even more NPs which neither work in vivo nor are immune to batch-wise variation. Upscaling remains a significant challenge and very little progress has been achieved so far. Universities are often not equipped for large-scale production of NPs given the significant biohazard concerns plus infrastructural requirements and industrial participation for upscaling of NP synthesis remains far from adequate. Therefore, significant challenges with process engineering continue to hurt the nanomedicine research.
http://www.future-science.com/doi/10.4155/ipk-2016-0017
Sound familiar?